Latest total revenue for GLPG: $990M, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Galapagos NV (GLPG) currently reports a total revenue of $990M as of June 2026. That compares with $280M in the prior-year period — up 259.5% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Galapagos NV's total revenue history and peer comparisons.
Galapagos NV's total revenue increased from $280M to $990M — a 259.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Galapagos NV's total revenue of $990M is lower than the Healthcare sector average of $110B. That is roughly 99.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Galapagos NV reported $990M in total revenue as of June 2026. That compares with $280M in the prior-year period — up 259.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total revenue of $990M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Galapagos NV, and consider following GLPG for alerts when major investors trade the stock.